Localization of lipoprotein lipase in the diabetic heart: Regulation by acute changes in insulin

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 6, 1999, Pages 1526-1534

  Sambandam, Nandakumar ^a   Abrahani, Mohammed A ^a   St Pierre, Edith ^a   Al Atar, Osama ^a   Cam, Margaret C ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diabetes; Insulin; Langendorff perfused heart; Lipoprotein lipase

Indexed keywords

INSULIN; LIPOPROTEIN LIPASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART MUSCLE PERFUSION; HYPOINSULINEMIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0032983401     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.6.1526     Document Type: Article

References (49)

1. Braun JEA, Severson DL. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J. 1992;287:337-347.
2. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med. 1989;320:1060-1068.
3. Camps L, Reina M, Llobera M, Vilaro M. Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am J Physiol. 1990; 258:673-681.
4. O'Brien KD, Ferguson M, Gordon D, Deeb SS, Chait A. Lipoprotein lipase is produced by cardiac myocytes rather than interstitial cells in human myocardium. Arterioscler Thromb. 1994;14:1445-1451.
5. Maulder M, Lombardi P, Jansen H, Van Berkel TJ, Frants RR, Havekes LM. Low density lipoprotein receptor internalizes low density and very low density lipoproteins which are bound to heparan sulphate proteoglycans via lipoprotein lipase. J Biol Chem. 1993;268:9369-9375.
6. Rutledge JC, Goldberg IJ. Lipoprotein lipase (LPL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LPL increases LDL accumulation in vascular tissue. J Lipid Res. 1994;35: 1152-1160.
7. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem. 1995;270:15747-15754.
8. Tavangar K, Murata Y, Patel S, Kalinyak JE, Pedersen ME, Goers JF, Hoffman AR, Kraemer FB. Developmental regulation of lipoprotein lipase in rats. Am J Physiol. 1992;262:330-337.
9. Farese RV, Yost TJ, Eckel RH. Tissue specific regulation of lipoprotein lipase activity by insulin/glucose in normal weight humans. Metabolism. 1991;40:214-216.
10. Levak-Frank S, Rander H, Walsh A, Stollberger R, Knipping G, Hoefer G, Sattler W, Weinstock PH, Breslow JL, Zechner R. Muscle specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest. 1995;696:976-986.
11. Doolittle MH, Ben-Zeev O, Elovson J, Martin D, Kirchgessner TG. The response of lipoprotein lipase to feeding and fasting: evidence for post-translational regulation. J Biol Chem. 1990;265:4570-4577.
12. Tavangar K, Murata Y, Pederson ME, Goers JF, Hoffman AR, Kraemer FB. Regulation of lipoprotein lipase in the diabetic rat. J. Clin. Invest. 1992;90:1672-1678.
13. Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes. 1997;46:1346-1353.
14. Lovich MA, Edelman ER. Mechanisms of transmural heparin transport in the rat abdominal aorta after local vascular delivery. Circ Res. 1995;77: 1143-1150.
15. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC37919). Cancer Chemother Rep. 1963;29: 91-98.
16. Junod A, Lambert AE, Stauffacher W, Renold AE. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest. 1969;48:2129-2139.
17. DeDeckere EAM, Hoor PT. A modified Langendorff technique for metabolic investigations. Pflugers Arch. 1977;370:103-105.
18. Jansen H, Stam H, Kalkman C, Hulsmann WC. On the dual localization of lipoprotein lipase in rat heart: studies with a modified perfusion technique. Biochem Biophys Res Commun. 1980;92:411-416.
19. de Lannoy LM., Jan Danser AH, van Kats JP, Schoemaker RG, Saxena PR, Schalekamp MADH. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart: local production of angiotensin I. Hypertension. 1997;29:1240-1251.
20. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol. 1993;4:187-196.
21. Rodrigues B, Spooner M, Severson DL. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts. Am J Physiol. 1992;262:216-223.
22. Olivecrona T, Bengtsson-Olivecrona G, Chernick SS, Scow RO. Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes: demonstration of inactive forms of lipase in cells. J Biol Chem. 1987;262: 10748-10759.
23. Anderson LG, Carroll AR, Ewart S, Acharya A, Severson DL. Fatty acids reduce heparin-releasable lipoprotein lipase activity in cultured cardio-myocytes from the rat heart. Am J Physiol. 1997;273:759-767.
24. Blanchette-Mackie EJ, Masuno H, Dwyer NK, Olivecrona T, Scow RO. Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol. 1989;256:818-828.
25. Eckel RH. Adipose tissue lipoprotein lipase. In: Borensztajn J, ed. Lipoprotein Lipase. Chicago. Ill: Evener; 1987:79-132.
26. Sadur CN, Eckel RH. Insulin stimulation of adipose tissue lipoprotein lipase: use of the euglycemic clamp technique. J Clin Invest. 1982;69: 1119-1125.
27. Ong JM, Kirchgessner TG, Schotz MC, Kern PA. Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes. J Biol Chem. 1988;263:12933-12938.
28. Braun JEA, Severson DL. Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes. Am J Physiol. 1991; 260:477-485.
29. Braun JEA, Severson DL. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not by insulin. Am J Physiol. 1992;260:663-670.
30. Semb H, Olivecrona T. Nutritional regulation of lipoprotein lipase in guinea pig tissues. Biochim Biophys Acta. 1986;876:249-255.
31. Blanchette-Mackie EJ, Dwyer NK, Amende LA. Cytochemical studies of lipid metabolism: immunogold probes for lipoprotein lipase and cholesterol. Am J Anat. 1989;185:255-263.
32. Yanagishita M, Hascall VC. Cell surface heparan sulfate proteoglycans. J Biol Chem. 1992;267:9451-9454.
33. Eckel RH, Fujimoto WY, Brunzell JD. Insulin regulation of lipoprotein lipase in cultured 3T3-L1 cells. Biochem Biophys Res Commun. 1978; 84:1069-1075.
34. Spooner PM, Chernick SS, Garrison MM, Scow RO. Insulin regulation of lipoprotein lipase activity and release in 3T3-L1 adipocytes: separation and dependence of hormonal effects on hexose metabolism and synthesis of RNA and protein. J Biol Chem. 1979;254: 10021-10029.
35. Chan BL, Lisanti MP, Rodriguez-Boulan E, Saltiel AR. Insulin mediated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor. Science. 1988;241:1670-1672.
36. Liu G, Olivecrona T. Pulse-chase study on lipoprotein lipase in perfused guinea pig heart. Am J Physiol. 1991;261:2044-2050.
37. Stins MF, Maxfield FR, Goldherg IJ. Polarized binding of lipoprotein lipase to endothelial cells: implications for its physiological actions. Arterioscler Thromb. 1992;12:1437-1446.
38. Wallinder L, Peterson J, Bengtsson-Olivecrona G, Olivecrona T. Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase. Biochim Biophys Acta. 1984;795:513-524.
39. Olivecrona T, Bengtsson-Olivecrona G. Heparin and lipases. In: Lane D, Lindahl H, eds. Heparin. London. England: Arnold: 1989:335-362.
40. Olivecrona T, Bergo M, Hultin M, Olivecrona G. Nutritional regulation of lipoprotein lipase. Can J Cardiol. 1995;11:73G-78G.
41. Saxena U, Klein MG, Goldberg IJ. Metabolism of endothelial cell-bound lipoprotein lipase: evidence for heparan sulfate proteoglycan-mediated internalization and recycling. J Biol Chem. 1990;265:12880-12886.
42. Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischémie injury is decreased. Cardiovasc Res. 1997:34:113-120.
43. Rodrigues B, McNeill JH. The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res. 1992;26:913-922.
44. Rodrigues B, Cam MC, McNeill JH. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol. 1995;27: 169-179.
45. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J. 1980;191: 421-427.
46. Del Rio AL, Sandalio LM, Palma JM, Bueno P, Corpas FJ. Metabolism of oxygen radicals in peroxisomes and cellular implications. Free Radic Biol Med. 1991;3:557-580.
47. Hennig B, Shasby DM, Fulton AB, Spector AA. Exposure to free fatty acids increases the transfer of albumin across cultured endothelial monolayers. Arteriosclerosis. 1984;4:489-497.
48. Rutledge JC, Woo MM, Rezai AA, Curtiss LK, Goldberg IJ. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res. 1997;80:819-828.
49. Randle PJ, Hales CN, Garland PB, Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.